Athanase Innovation Q2 operating loss narrows to SEK 13.3 million; net sales drop to SEK 1.8 million

• Athanase Innovation posted a Q2 operating loss of SEK 13.3 million, narrowing from SEK 27.2 million a year earlier.
• Net sales fell to SEK 1.8 million from SEK 5.4 million, while securities fair-value changes swung to a gain of SEK 8.1 million from a loss of SEK 10.7 million.
• For H1, operating loss narrowed to SEK 22.9 million from SEK 36.4 million; net sales dropped to SEK 3.9 million from SEK 11.5 million.
• H1 securities fair-value changes swung to a gain of SEK 19.7 million from a loss of SEK 2.6 million.
• IVISYS settled its patent dispute with CHEP with no admission of wrongdoing; management cited orders for three new PalletAI systems from existing customers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Athanase Innovation AB published the original content used to generate this news brief on July 10, 2026, and is solely responsible for the information contained therein.